Course Overview

Scientific Sessions and Clinical Review a 2009 is 3-day annual conference held by the University Chicago Pritzker School of Medicine in Napa, California. The 2009 Scientific Sessions represent the forefront of continuing medical education and the 3rd year of this educational initiative. University of Chicago faculty will present recent scientific advances that allow us to step in front of the disease curve, and address illness in a more specific and “personalized” approach than ever before. This interactive course will highlight new approaches to the prevention and management of cardiovascular disease, diabetes, depression, gastrointestinal disorders and cancer, and allow practical strategies to be implemented in every physician’s practice.

Learning Objectives

• Identify the latest advances in the use of biomarkers, imaging and genomics for the prevention of cardiovascular disease
• Understand managing dyslipidemia to reduce CHD risk, including the use of statins in primary prevention and long-term LDL reduction and the benefits of HDL raising therapies
• Evaluate predictors of type 2 diabetes, and how to manage cardiometabolic risk in patients with early type 2 diabetes using lifestyle intervention and pharmacotherapy
• Assess developing strategies for prevention of various cancers, including the use of vaccines and chemoprevention, and review current guidelines for cancer screening
• Examine genetic screening as a viable tool for predicting specific CVD states, cancers and diabetes
• Recognize the association of increased depressive symptoms and disorders with the worsening of chronic disease states, and identify strategies for early detection and treatment of depression
• Understand the risks and benefits of biologic therapy and chronic immune-mediated inflammatory disorders
• Review the current concepts of hospital medicine and medical informatics

Target Audience

Primary care physicians, internists, hospitalists, and program directors.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Chicago Pritzker School of Medicine and AcademicCME. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Chicago Pritzker School of Medicine designates this educational activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty/Planner Disclosure Policy

It is the policy of the University of Chicago Center for Continuing Medical Education to ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational activities. All individuals in a position to influence the content or development of this educational activity are required to disclose to the activity participants: 1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/material; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

In compliance with the ACCME’s updated accreditation criteria, presentations of those with reported potential conflicts were reviewed prior to presentation. In addition, speakers were asked to reference the best available evidence in their presentations. Conference attendees will be asked to evaluate the objectivity of each presentation.

Disclaimer

Faculty, topics, schedule, and credit hours are subject to change.

The views expressed in this activity are those of the individual speaker. It should not be inferred or assumed that they are expressing the views of any pharmaceutical or product/device manufacturer, provider of commercial services, AcademicCME, or the University of Chicago. The drug selection and dosage in formation presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.

Copyright© 2009 University of Chicago. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from University of Chicago Center for Continuing Medical Education.

Accessibility Statement

Agenda

Thursday, August 6, 2009

Early Disease Detection & Prevention: Entering the Era of Personalized Medicine
Moderator: Michael H. Davidson, MD

Friday, August 7, 2009

Updates in Cardiology for Primary Care

Saturday, August 8, 2009

Clinical Reviews of Internal Medicine
Moderator: Edward R. Garrity Jr., MD

Faculty

Program Chair:

Everett E. Vokes MD

Chairman, Department of Medicine
Director, Section of Hematology/Oncology
Deputy Director, Cancer Research Center
John E. Ultmann Professor of Medicine
Radiation and Cellular Oncology
The University of Chicago Medical Center
Chicago, IL

Course Directors:

Michael H. Davidson, MD, FACC

Clinical Professor of Medicine
Director, Preventive Cardiology
Associate Vice Chair for CME,
Department of Medicine
The University of Chicago Medical Center
Chicago, IL
Executive Medical Director
Radiant Research

Edward R. Garrity, Jr., MD

Professor of Medicine
Vice Chair for Clinical Operations
Associate Director, Transplantation Services
The University of Chicago Medical Center
Chicago, IL

Stephen B. Hanauer, MD

Professor of Medicine and Clinical Pharmacology
Chief, Section of Gastroenterology, Hepatology and Nutrition
The University of Chicago Medical Center
Chicago, IL

Visiting Professor:

Eric J. Topol, MD

The Gary and Mary West Chair of Innovative Medicine
Director, Scripps Translational Science Institute [STSI]
Chief Academic Officer, Scripps Health
La Jolla, CA

Educational grant funding
for this activity has been received
from the following:
Centocor
DeCode
Lilly
Merck
Merck/Schering-Plough
Novo Nordisk
Roche
Takeda
Tethys
United Therapeutics

Joint Sponsor: